Intralobar Pulmonary Sequestration and Increased Serum CA 19-9 [PDF]
European Journal of Case Reports in Internal Medicine, 2017 Intralobar pulmonary sequestration is an uncommon congenital lung anomaly which consists of a mass of normal lung tissue not connected to the normal tracheobronchial tree and supplied by an anomalous systemic artery.
Massimo Montalto +4 more
doaj +4 more sources
The Significance of Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, Calcium and Zinc as Biomarkers in Sera of Colorectal Cancer Patients [PDF]
مجلة بغداد للعلومColorectal cancer (CRC) is a disease that begins exclusively in the colon or rectum and is caused by an abnormal proliferation of glandular epithelial cells in the colon. Carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), calcium (Ca),
Fenik Ahmed Nadir, Zeyan Abdullah Ali
doaj +2 more sources
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer
The International Journal of Biological Markers, 1995 In order to assess the utility of the tumor-associated antigen CA 72-4 in the diagnosis and monitoring of gastric cancer, this tumor marker was measured preoperatively in 718 patients.
F. Safi, V. Kuhns, H.G. Beger
doaj +2 more sources
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. [PDF]
PLoS ONE, 2017 OBJECTIVES:Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features.
Sofi Isaksson +7 more
doaj +2 more sources
Identification of blood-protein carriers of the CA 19-9 antigen and characterization of prevalence in pancreatic diseases. [PDF]
Proteomics, 2011 The current best serum marker for pancreatic cancer, CA 19‐9, detects a carbohydrate antigen on multiple protein carriers. Better knowledge of the protein carriers of the CA 19‐9 antigen in various disease states may lead to improved diagnostic tests. To
Yue T +9 more
europepmc +2 more sources
Reference Limits for Chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and Carcinoembryonic Antigen in Patients with Chronic Kidney Disease [PDF]
The International Journal of Biological Markers, 2017 Background Patients with chronic kidney disease (CKD) may have increased plasma concentrations of some tumor markers even when no cancer is present.
Gustav Mikkelsen +4 more
doaj +2 more sources
Elevated carbohydrate antigen 19-9 (CA 19-9) in patients with Echinococcus infection. [PDF]
, 2001 The carbohydrate antigen 19-9 (CA 19-9), a determinant (sialylated lacto-N-fucopentaose 119) of a circulating oligosaccharide antigen, is a frequently used tumor marker. Echinococcus spp.
Cerny, A +4 more
core +3 more sources
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]
, 2007 Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan +5 more
core +1 more source
Are serial CA 19-9 kinetics helpful in predicting survival in patients with advanced or metastatic pancreatic cancer treated with gemcitabine and cisplatin? [PDF]
, 2003 Background: Serial kinetics of serum CA 19-9 levels have been reported to reflect response and survival in patients with pancreatic cancer undergoing surgery, radiotherapy, and chemotherapy.
Stoffregen, C. +11 more
core +1 more source
Tumor associated antigens in diagnosis of serous effusions [PDF]
, 1988 The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W. +4 more
core +1 more source